Tang 2015.

Methods	Allocation: randomised Blinding: not reported Duration: not reported Location: not reported Length of follow‐up: not reported
Participants	Diagnosis: first‐episode schizophrenia Total: N = 120 Sex: not reported Age: not reported Length of illness: not reported Inclusion criteria: not reported Exclusion criteria: not reported
Interventions	1. CBT plus palperidone palmitate group 2. Paliperidone palmitate group
Outcomes	Mental state: no clinical response, PANSS score Adverse events: TESS score General functioning: relapse, rehospitalisation, individual/social function ‐ PSP score Satisfaction with treatment: MSQ score
Notes	Awaiting full text